The relationship between pruritus and the clinical signs of psoriasis in patients receiving tofacitinib

Journal of Dermatological Treatment

Volumn 26, Issue 1, 2015, Pages 19-22

  Bushmakin, Andrew G ^a   Mamolo, Carla ^a   Cappelleri, Joseph C ^a   Stewart, Michelle ^a  

^a PFIZER INC   (United States)

Author keywords

Erythema; Induration; Mediation modeling; Plaque psoriasis; Pruritus; Scaling; Tofacitinib

Indexed keywords

PLACEBO; TOFACITINIB; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ADULT; ARTICLE; BODY SURFACE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ERYTHEMA; FEMALE; HUMAN; ITCH SEVERITY SCORE; MAJOR CLINICAL STUDY; MALE; OUTCOME VARIABLE; PATHOGENESIS; PATIENT GLOBAL ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TEST RETEST RELIABILITY; TREATMENT DURATION; TREATMENT OUTCOME; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; PSORIASIS; PSYCHOMETRY; REPRODUCIBILITY;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERIDINES; PROTEIN KINASE INHIBITORS; PRURITUS; PSORIASIS; PSYCHOMETRICS; PYRIMIDINES; PYRROLES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84924286029     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2013.861891     Document Type: Article

References (20)

1. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009;61: 451-85.
2. Chang SE, Han SS, Jung HJ, Choi JH. Neuropeptides and their receptors in psoriatic skin in relation to pruritus. Br J Dermatol. 2007;156:1272-7.
3. Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124:1052-7.
4. Reich A, Orda A, Wisnicka B, Szepietowski JC. Plasma neuropeptides and perception of pruritus in psoriasis. Acta Derm Venereol. 2007;87:299-304.
5. Szepietowski JC, Reich A, Wisnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 2002;10:221-6.
6. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol. 2000;143:969-73.
7. Globe D, Bayliss MS, Harrison DJ. The impact of itch symptoms in psoriasis: results from physician interviews and patient focus groups. Health Qual Life Outcomes 2009;7:62.
8. Dawn A, Yosipovitch G. Treating itch in psoriasis. Dermatol Nurs. 2006;18:227-33.
9. Prignano F, Ricceri F, Pescitelli L, Lotti T. Itch in psoriasis: epidemiology, clinical aspects and treatment options. Clin Cosmet Investig Dermatol. 2009;2:9-13.
10. Papp K, Menter A, Strober B, et al. Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study. Br J Dermatol. 2012;167:668-77.
11. Mamolo C, Harness J, Tan H, Menter A. Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2013 [Epub ahead of print]. doi: 10.1111/jdv.12081.
12. Mamolo CM, Bushmakin AG, Cappelleri JC, Stewart M. The effect of oral CP-690,550 on pruritus in patients with moderate-to-severe plaque psoriasis. Value Health. 2011;14:A56.
13. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-16.
14. Cappelleri JC, Bushmakin AG, Harness J, Mamolo C. Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity. Qual Life Res. 2013 [Epub ahead of print]. doi:10.1007/s11136-013-0384-y.
15. Stevens J. Applied Multivariate Statistics for the Social Sciences. Hillsdale, NJ: Lawrence Erlbaum, 2002.
16. nd ed. New York: Routledge Academic, 1988.
17. nd ed. Chichester, England: John Wiley and Sons Ltd, 2007.
18. Iacobucci D. Mediation Analysis. Thousand Oaks, CA: SAGE Publications, 2008.
19. MacKinnon DP. Introduction to Statistical Mediation Analysis. New York, NY: Lawrence Erlbaum Associates, 2008.
20. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826-50.